Page last updated: 2024-11-05

5-aminouracil

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

5-Aminouracil is a pyrimidine analog that exhibits anticancer activity. It was first synthesized in 1954 and has been studied extensively for its potential as a chemotherapeutic agent. 5-aminouracil inhibits the synthesis of DNA and RNA by competing with uracil for incorporation into these molecules. The compound has shown promising results in preclinical studies against a variety of cancers, including leukemia, lymphoma, and colorectal cancer. However, clinical trials have been limited due to its toxic effects, which include bone marrow suppression and gastrointestinal toxicity. Despite these challenges, 5-aminouracil continues to be investigated for its potential as a chemotherapeutic agent, particularly in combination with other drugs. Recent research has focused on developing new derivatives of 5-aminouracil with improved therapeutic index. Furthermore, 5-aminouracil has been explored for its potential in other medical applications, such as antiviral and antifungal therapies. Its ability to inhibit the synthesis of nucleic acids makes it a promising candidate for the treatment of viral and fungal infections.'

Cross-References

ID SourceID
PubMed CID13611
CHEMBL ID1236704
SCHEMBL ID65085
MeSH IDM0057260

Synonyms (52)

Synonym
CHEMBL1236704
2,3h)-pyrimidinedione, 5-amino-
uracil, 5-amino-
nsc22474
932-52-5
nsc-22474
5-aminouracil
5-amino-2,4-dihydroxypyrimidine
2,4-dihydroxy-5-aminopyrimidine
2,4(1h,3h)-pyrimidinedione, 5-amino-
5-amino-1h-pyrimidine-2,4-dione
inchi=1/c4h5n3o2/c5-2-1-6-4(9)7-3(2)8/h1h,5h2,(h2,6,7,8,9
5-aminopyrimidine-2,4(1h,3h)-dione
wbu ,
5-aminouracil, 98%
DB03792
uracil, 5-amino- (van)
ai3-50678
nsc 22474
einecs 213-252-3
A-7410
A0898
AKOS001603829
A844487
5-azanyl-1h-pyrimidine-2,4-dione
unii-r2o7eky9g9
r2o7eky9g9 ,
BBL011353
5-amino-2,4-pyrimidinediol
STL146443
F3096-1977
FT-0620029
SCHEMBL65085
5-aminopyrimidine-2,4-diol
AM83915
aminouracil, 5-
5-amino-2,4(1h,3h)-pyrimidinedione
DTXSID1061312
5-amino-2,4(1h,3h)-pyrimidinedione #
mfcd00006025
J-800160
5-amino uracil
SY035728
F16509
BP-30253
Q27094684
AS-11275
2,4-dioxo-5-aminopyrimidine
EN300-95642
5-amino-1,2,3,4-tetrahydropyrimidine-2,4-dione
PD007236
Z276550526
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID691395Drug degradation in DMSO2012Bioorganic & medicinal chemistry letters, Oct-15, Volume: 22, Issue:20
Compound instability in dimethyl sulphoxide, case studies with 5-aminopyrimidines and the implications for compound storage and screening.
AID691413Drug degradation in DMSO assessed as murexide by UV-Vis spectrophotometry2012Bioorganic & medicinal chemistry letters, Oct-15, Volume: 22, Issue:20
Compound instability in dimethyl sulphoxide, case studies with 5-aminopyrimidines and the implications for compound storage and screening.
AID691419Drug degradation in DMSO assessed as 5-aminobarbiturate formation by UV-Vis spectrophotometry2012Bioorganic & medicinal chemistry letters, Oct-15, Volume: 22, Issue:20
Compound instability in dimethyl sulphoxide, case studies with 5-aminopyrimidines and the implications for compound storage and screening.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (30)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (30.00)18.7374
1990's4 (13.33)18.2507
2000's6 (20.00)29.6817
2010's8 (26.67)24.3611
2020's3 (10.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 26.92

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index26.92 (24.57)
Research Supply Index3.43 (2.92)
Research Growth Index4.55 (4.65)
Search Engine Demand Index25.99 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (26.92)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other29 (96.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]